www.fgks.org   »   [go: up one dir, main page]

Dow 25,189.23 144.94 0.58%
S&P 500 2,813.61 6.63 0.24%
Nasdaq 7,818.21 -23.66 -0.30%
GlobalDow 3,057.21 21.22 0.70%
Gold 1,234.70 0.30 0.02%
Oil 68.76 0.87 1.28%
BEUSOpenBack To Top
Last Updated: EDT

$ 0.00

0.00 0.00%
Previous Close
$-
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
Open: 0.00
Last: 0.00
0 Day Low/High 0

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $0.00
  • Day Range 0 - 0
  • 52 Week Range
  • Market Cap n/a
  • Shares Outstanding n/a
  • Public Float n/a
  • Beta n/a
  • Rev. per Employee $325.87K
  • P/E Ratio n/a
  • EPS n/a
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest n/a
  • % of Float Shorted n/a

Performance

5 Day n/a
1 Month n/a
3 Month n/a
YTD n/a
1 Year n/a

Recent News

  • MarketWatch
  • Other Dow Jones
Bloom Energy IPO: 5 things to know about the Silicon Valley clean-energy ‘unicorn’

Bloom Energy IPO: 5 things to know about the Silicon Valley clean-energy ‘unicorn’

IPO boom has opened the window for some scary companies

IPO boom has opened the window for some scary companies

Bloom Energy sets IPO terms, seeking to sell up to $252 million in shares

Bloom Energy Corp. has set the terms of its initial public offering, seeking to sell 18 million shares between $13 and $15 a piece to raise up to $252 million, according to a filing Monday. Bloom, a clean-energy "unicorn," or a privately held startup valued at more than $1 billion, had filed the initial paperwork last month with a placeholder amount of $100 million. The Sunnyvale, Calif., company hopes to trade on the New York Stock Exchange under the ticker symbol BE. Underwriters include J.P. Morgan, Morgan Stanley, and Credit Suisse.

On Eve of IPO, Bloom Energy Faces Questions About Settlement With Investors

As it prepares for its IPO, Bloom Energy faces questions about why it paid millions in a settlement to investors.

  • on The Wall Street Journal

Recent News

  • Other News
  • Press Releases

On Eve of IPO, Bloom Energy Faces Questions About Settlement With Investors

As it prepares for its IPO, Bloom Energy faces questions about why it paid millions in a settlement to investors.

  • on The Wall Street Journal

Stocks To Watch: FANGs Out In Tech

Stocks To Watch: FANGs Out In Tech

  • on Seeking Alpha

Beleave Rapidly Accelerates its Recreational Distribution Strategy by Acquiring Seven Oaks

Beleave Rapidly Accelerates its Recreational Distribution Strategy by Acquiring Seven Oaks

  • on CNW Group

Bloom Energy IPO: Undervalued At 2.6x Forward Sales

Bloom Energy IPO: Undervalued At 2.6x Forward Sales

  • on Seeking Alpha

Bloom Energy Aims For $252 Million IPO

Bloom Energy Aims For $252 Million IPO

  • on Seeking Alpha

Beleave Subsidiary Reaches Agreement to Lease 27 Hectares of Land in Colombia

Beleave Subsidiary Reaches Agreement to Lease 27 Hectares of Land in Colombia

  • on CNW Group

Bloom Energy Seeks IPO As Revenue Grows

Bloom Energy Seeks IPO As Revenue Grows

  • on Seeking Alpha

Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization

Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization

  • on CNW Group

Beleave Expands its Global Footprint into Colombia

Beleave Expands its Global Footprint into Colombia

  • on CNW Group

Fuel Cell Company Bloom Energy Prepares For Market Debut

Fuel Cell Company Bloom Energy Prepares For Market Debut

  • on Seeking Alpha

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease

  • on BusinessWire - BZX

Partner Content